Comprehensive assessment of the prognosis of pancreatic cancer: Peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour site

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 5, 2016, Pages 610-617

  Takakura, Kazuki ^a,d   Ito, Zensho ^a   Suka, Machi ^a   Kanai, Tomoya ^a   Matsumoto, Yoshihiro ^a   Odahara, Shunichi ^a   Matsudaira, Hiroshi ^a   Haruki, Koichiro ^a   Fujiwara, Yuki ^a   Saito, Ryota ^a   Gocho, Takeshi ^a   Nakashiro, Koh Ichi ^b   Hamakawa, Hiroyuki ^b   Okamoto, Masato ^c   Kajihara, Mikio ^a   Misawa, Takeyuki ^a   Ohkusa, Toshifumi ^a   Koido, Shigeo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Immunohistochemistry; neutrophil lymphocyte ratio; pancreatic cancer; prognosis

Indexed keywords

ALBUMIN; AMYLASE; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CD163 ANTIGEN; CD20 ANTIGEN; HEMOGLOBIN; LACTATE DEHYDROGENASE;

AGED; ALBUMIN BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DENSITY; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; THROMBOCYTE COUNT; BLOOD; EPIDEMIOLOGY; FOLLOW UP; JAPAN; LEUKOCYTE COUNT; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TRENDS; TUMOR VOLUME;

AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; NEUTROPHILS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TUMOR BURDEN;

EID: 84956825116     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1121515     Document Type: Article

References (41)

1. Ino Y, Yamazaki-Itoh R, Shimada K., et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer. 2013; 108: 914-923
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674
3. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-867
4. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001; 357: 539-545
5. Jaiswal M, LaRusso NF, Burgart LJ., et al. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 2000; 60: 184-190
6. Mantovani A, Allavena P, Sica A., et al. Cancer-related inflammation. Nature. 2008; 454: 436-444
7. Pichler M, Hutterer GC, Stoeckigt C., et al. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer. 2013; 108: 901-907
8. Walsh SR, Cook EJ, Goulder F., et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005; 91: 181-184
9. Wang DS, Luo HY, Qiu MZ., et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012; 29: 3092-3100
10. Stotz M, Gerger A, Eisner F., et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013; 109: 416-421
11. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanisms of suppression of t-cell function in advanced cancer patients. Cancer Res. 2001; 61: 4756-4760
12. Lepique AP, Daghastanli KR, Cuccovia IM., et al. HPV16 tumor associated macrophages suppress antitumor T cell responses. Clin Cancer Res. 2009; 15: 4391-4400
13. Galdiero MR, Bonavita E, Barajon I., et al. Tumor associated macrophages and neutrophils in cancer. Immunobiology. 2013; 218: 1402-1410
14. Donskov F, Bennedsgaard KM, Hokland M., et al. Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma. Cancer Immunol Immunother. 2004; 53: 729-739
15. Yoshikawa K, Mitsunaga S, Kinoshita T., et al. Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci. 2012; 103: 2012-2020
16. Jamieson NB, Mohamed M, Oien KA., et al. The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2012; 19: 3581-3590
17. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140: 883-899
18. Kurahara H, Shinchi H, Mataki Y., et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011; 167: e211-e219
19. Kusumanto YH, Dam WA, Hospers GA., et al. Platelets and granulocytes, in particular the neutrophils, from important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003; 6: 283-287
20. Golay JT, Clark EA, Beverley PC. The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle. J Immunol. 1985; 135: 3795-3801
21. Mahmoud SM, Lee AH, Paish EC., et al. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat. 2012; 132: 545-553
22. Al-Shibli KI, Donnem T, Al-Saad S., et al. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res. 2008; 14: 5220-5227
23. Milne K, Köbel M, Kalloger SE., et al. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One. 2009; 4: e6412
24. Bhatti I, Peacock O, Lloyd G., et al. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010; 200: 197-203
25. Clark CE, Hingorani SR, Mick R., et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 2007; 67: 9518-9527
26. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004; 21: 137-148
27. Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol. 2010; 28: 4045-4051
28. Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 2008; 267: 204-215
29. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4: 71-78
30. Mantovani A, Romero P, Palucka AK., et al. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet. 2008; 371: 771-783
31. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006; 66: 605-612
32. Sica A, Schioppa T, Mantovani A., et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Euro J Cancer. 2006; 42: 717-727
33. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006; 124: 263-266
34. Mantovani A, Marchesi F, Porta C., et al. Inflammation and cancer: breast cancer as a prototype. Breast. 2007; 16Suppl2: S27-S33
35. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol. 2004; 122: 794-801
36. Ambarus CA, Krausz S, van Eijk M., et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods. 2012; 376: 196-206
37. + neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer. Br J Cancer. 2013; 108: 2116-2122
38. Fridlender ZG, Sun J, Kim S., et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell. 2009; 16: 183-194
39. Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013; 23: 200-207
40. Rabinowich H, Cohen R, Bruderman I., et al. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res. 1987; 47: 173-177
41. Hoffmann TK, Dworacki G, Tsukihiro T., et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 2002; 8: 2553-2562